Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-498-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
The bioavailability of the substance can be confirmed through different routes. But the uptake may be limited due to the phys-chem. behaviour. Possible uptake routes are dermal, oral and inhalation, whereas via dermal and inhalation route the absorption is expected to be lower. It can be assumed that the substance is not wide distributed and unlikely to accumulate. A main route of elimination could not be concluded, but renal and bile excretion may be the main path for excretion.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
- Absorption rate - oral (%):
- 100
- Absorption rate - dermal (%):
- 10
- Absorption rate - inhalation (%):
- 100
Additional information
There were no studies available in which the toxicokinetic properties (distribution, metabolism, elimination) of the Reaction product of fatty acids C14-18/C16-18 unsaturated with dihydrogendioxide and Ammonia were investigated.
The expected toxicokinetic behaviour is derived from the physicochemical properties, the results from the available toxicological studies and the available literature following the information given in guidance document 7c.
Please note that the real behaviour may be different but can only be determined with ADME studies, which aren’t justified based on the very low toxicity of the substance.
Reaction product of fatty acids C14-18/C16-18 unsaturated with dihydrogendioxide and Ammonia having a molecular weight of ~ 333 g/mol is a pastose (handle as liquid solutions) with a water solubility of 0.34g/l . It has a low volatility of < 11 Pa and a hydrophilic character (log Pow = 1.48). The structure shows ionisable elements and the hydrolysis test shows hydrolysis stability at all tested temperature. The surface tension is 42.9 mN/m.
Oral and GI absorption:
Based on the physicochemical data the substance is suspected to be less dissolvable in GI and absorbed via passive diffusion. As the substance is hydrolytically stable an increased hydrolysis in the gastric fluid is not expected (due to phy-chem. parameter, enzymatic hydrolysis may possible) and the parent compound may represent the major compartment. Low toxicity seen in acute and long term test point to low systemic toxicity. Partly the substance may be dissociating and ions may be thereafter more easily be taken up. In summary due to the molecular weight and phys-chem. behaviour the substance may be absorbed orally / via GI tract. But the amount may be limited.
Inhalation absorption:
Derived from the physicochemical data the substance has a less volatility is therefore only inhaled in very low concentration. No dust may be occurring as the substance is pastose or handle as dilutions. Absorption, if the substance is inhaled, may happen in the mucosa via passive diffusion. Nevertheless due to less hydrophilic character the substance may also reach lower respiratory regions. Nevertheless the substance may partly dissociate and the dissociated components may be more retained in the upper mucosa due to the higher hydrophilic properties. As no hydrolysis of the substance in biological fluids is expected (excluding enzymatic), absorptions (if happened) of the parent component is expected.
In summary only very limited inhalation absorption is expected, due to the low exposure and absorption of the substance in the upper mucosa.
Dermal absorption:
Triggered by the physicochemical data the following dermal absorption behaviour is expected but not confirmed: Due to pastose state of the substance it can be easily distributed on the skin surface. The low vapour pressure increases the dermal contact time. But the low water solubility and log pow are strongly limiting the dermal absorption. As there also no or only slight effects seen in dermal contact tests, no increased absorption due to skin damage is expected. Nevertheless as the substance has the ability to dissociate, the ions may be more up taken due to the higher solubility. In summary a low dermal absorption is expected, but dermal absorption cannot fully exclude.
Second it is known for cosmetic ingredients having a MW below 300 g/mol and a log pow between -1 and 5 that an dermal absorption of 10% can be expected (Kroes et al., Food Chem Toxicol 2007 Dec; 45(12): 2533-62). As there are structural similarities between the substance and few cosmetic ingredients, hence for exposition calculation 10% dermal absorption is used as assumption.
Distribution:
Based on the physicochemical data the substance is expected to be less distributed in the organism due to their low water solubility. The molecular mass may also limit the distribution and the absence of systemic effects in repeated dose studies questions the systemic availability. Special targets for distribution could not be identified. Nevertheless all this behaviour is estimated, detailed information can only be obtained by ADME investigations.
Accumulative potential:
Based on the available data the substance accumulation of the substance is not expected.
Metabolism:
No detail information can be derived concerning the metabolism.
Reactivity:Available studies on genotoxicity were negative, i. e. there is no indication of a reactivity under the test conditions.
Excretion:
Based on the available information the expected behaviour of the substance is estimated: The ionic character may shift excretion to urine whereas the high molecular mass points to an excretion via bile. Nevertheless both routes are expected. If the substance is partly excreted via bile and is glucoronidated a reabsorption in the GI may be possible (enterohepatic circulation). As the substance is expected to not wide distributed, less amount in breast milk or saliva are expected. This expected behaviour is only estimated based on the few availalbe phys-chem. information, only detailed ADME investigation can confirm these behaviour. But based on the toxicological profile further investigation are not necessary as the substance has a very low (non) toxicity
In summary:The bioavailability of the substance can be confirmed through different routes. But the uptake may be limited due to the phys-chem. behaviour. Possible uptake routes are dermal, oral and inhalation, whereas via dermal and inhalation route the absorption is expected to be lower. It can be assumed that the substance is not wide distributed and unlikely to accumulate. A main route of elimination could not be concluded, but renal and bile excretion may be the main path for excretion.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.